23andMe

23andWe's mission is to foster a workplace that embodies respect and transparency, helps us empower one another, and provides access to opportunity for all employees.

ALL OF US ARE LINKED BY A SHARED THREAD – DNA.

23andMe is based on the foundation that all of us are linked by a shared thread – DNA – that we are genetically 99.5% the same. We share so much in common, yet if you are an underrepresented minority, have a disability, or are simply different, you will disproportionately experience injustices and prejudice that can put lives on completely different trajectories.

Investing our time, effort, and resources into improving Diversity, Equity, & Inclusion is simply the right thing to do.

WE BUILD AWARENESS AND ACCEPTANCE.

23andWe, a grassroots group of employee volunteers, drives our company’s DEI initiatives around hiring; employee experience; product and research; and the community. 23andWe is responsible for organizing internal events such as our DEI Book Club, internal podcasts, and external Speaker Series.

In addition, 23andWe is involved in ensuring we have equal representation in our hiring processes, our product, partnerships, and nonprofit organizations we support.

WE VALUE THE WHOLE SELF.

We want all of our employees to feel like they belong at 23andMe. We provide safe spaces for them to network, organize, and build community to make impactful changes.

Our employee resource groups, including Blacks@, Neurodiversity, Femingineers, LGBTQ+, 23andHear, and Parents@, are employee–led groups who join together around shared interests, life experiences, or characteristics to support each other and have their voices elevated within the company and community.

Our 23andGROW learning and development program provides continuous training to ensure that all employees have the tools to help their colleagues feel like they belong. These training sessions include Unconscious Bias, Microaggressions, and Allyship and Inclusivity.

Our mentorship program provides a platform for employees from all backgrounds and levels to come together in order to impact each other’s lives and experiences in a meaningful way.

WE CELEBRATE DIFFERENCES.

Sharing what makes us unique brings acceptance, empathy, and an overall healthy sense of community. We proudly celebrate cultural holidays and celebrations such as Lunar New Year, Black History Month, Autism Acceptance Month, Pride Month, Juneteenth, Disability Pride, and Diwali.

Think big.

We are a mission-driven company with big dreams of using data to revolutionize health, wellness, and research.

We heart DNA.

Deciphering the human genome is the most exciting scientific discovery of our lifetime.

Lead with science.

We make evidence-based decisions and use data to better understand wellness and improve disease.

Get to yes or no, quickly.

Pioneering often means there is not an obvious path forward, but we also recognize that indecision leads to failure.

Behind every data point is a human being.

In each drop of spit lies a whole story of ancestry, health & connectedness.

We’re in this together.

Diversity and opportunity matter – we know that great ideas come from everywhere and that everyone contributes to our success.

In the fall of 2021, 23andMe acquired the innovative telemedicine company Lemonaid Health to transform the primary care experience and make personalized healthcare, powered by genetic and non-genetic data, a reality. Together we are achieving our mission of helping people benefit from the human genome by empowering people to take control of their health and building a healthcare platform that focuses on prevention and wellness.

Why Diversity, Equity & Inclusion Matter

Our company is based on the foundation that all of us are linked by a shared thread, our DNA. We are all 99.5% genetically alike; our similarities are so much greater than any differences. It is a scientific fact. And yet, many people disproportionately experience injustices and prejudice that can put their lives on completely different trajectories.

• How 23andMe is supporting African-American Employees and Communities
• The DE&I Journey: An Interview with Melinda King, Head of DE&I

A New Foundation for Change

We created four key pillars to hold our leadership, employees and collaborators accountable.

1. Hiring - Hiring with diversity goals in mind.
2. Employee Experience - Building an inclusive culture so employees can bring their whole selves to work.
3. Product and R&D - Creating a product experience that is more equitable and inclusive.
4. Community Impact & Collaborations - Expanding collaborator representation and impacting communities where we work and live.

• Our Workforce Diversity

Health & Family Benefits

• Reimbursement of up to a lifetime maximum of $20,000 each for fertility, adoption, and/or surrogacy expenses, and 16 weeks of paid leave for parents
• Paid GENE-US Reset weeks in December and July in addition to three weeks of vacation time and two floating holidays
• 16 hours of Volunteer time-off
• Mental healthcare benefits for employees and their families
• Comprehensive health, vision, and dental plans with HMO, PPO and HDHP options

Financial Benefits

• Competitive compensation packages
• Monthly contributions toward student loans with our Student Loan Assistance benefit
• 401(k) company matching and choice of mutual funds
• Commuter benefits such as shuttles, Scoop, and Caltrain reimbursement
• $1,500 annual Tuition Reimbursement

Work Perks

• Two free 23andMe kits
• Onsite gym with free pilates, yoga, and meditation classes
• Free onsite cafe and snacks with vegan, halal, and kosher options
• Virtual cooking classses through 23andEat
• Dog-friendly Sunnyvale office & voluntary pet insurance

23andMe’s Therapeutics division focuses on research and drug development.

The team is committed to discovering and developing novel therapies to improve patient lives through the study of human genetics. We currently have research programs across several therapeutic areas, including but not limited to oncology, respiratory, and cardiovascular diseases. 

In July 2018, 23andMe and GlaxoSmithKline (GSK) signed an exclusive agreement to leverage genetic insights for the development of novel medicines. This multi-year collaboration is expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programs. Learn More